A detailed history of Shelton Wealth Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Shelton Wealth Management, LLC holds 571 shares of LLY stock, worth $536,614. This represents 0.28% of its overall portfolio holdings.

Number of Shares
571
Previous 521 9.6%
Holding current value
$536,614
Previous $303,000 46.53%
% of portfolio
0.28%
Previous 0.22%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$592.2 - $792.28 $29,610 - $39,614
50 Added 9.6%
571 $444,000
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $273,623 - $322,566
521 New
521 $303,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $893B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Shelton Wealth Management, LLC Portfolio

Follow Shelton Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shelton Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Shelton Wealth Management, LLC with notifications on news.